During the past decade, NRC Institute of Immunology FMBA of Russia conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "NRC Institute of Immunology FMBA of Russia" #1 collaborator was "St. Petersburg Research Institute of Vaccines and Sera" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "NRC Institute of Immunology FMBA of Russia" are "COVID-19" (2 trials), "Dermatitis, Atopic" (2 trials), "Atopic Dermatitis" (1 trials), "Dermatitis" (1 trials) and "Eczema" (1 trials). Many other conditions were trialed in "NRC Institute of Immunology FMBA of Russia" in a lesser frequency.

Most popular intervention types in "NRC Institute of Immunology FMBA of Russia" are "Drug" (5 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Abrocitinib 100 mg" (1 trials), "Abrocitinib 200 mg" (1 trials), "MIR 19 ®" (1 trials) and "PF-04965842 100 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "NRC Institute of Immunology FMBA of Russia" are 4 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "NRC Institute of Immunology FMBA of Russia". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in NRC Institute of Immunology FMBA of Russia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in NRC Institute of Immunology FMBA of Russia, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".